Journals / Turkish Journal of Medical Sciences / 2000 / Cilt: 30 - Sayı: 5

A case of carbamazepine-induced lymphocytic interstitial pneumonitis

Pages
509–510
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

DENİZ, Ö., BOZKANAT, E., ÇİFTÇİ, F., İLVAN, A., TOZKOPARAN, E., ÖZTÜRK, S. (2022). A case of carbamazepine-induced lymphocytic interstitial pneumonitis. Turkish Journal of Medical Sciences, Cilt: 30 - Sayı: 5, 509–510. https://ajindex.com/articles/612397

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Takahashi N, Aizawa H, Takata S, Matsumoto K, Koto H, Ünove H, Hara NAD. Acute interstitial pneumonitis induced by carbamazepine. Eur Respir J 6 (9): 1409-11, 1993
  2. Cooper JAD, White DA, Matthay RA. Drug-induced pulmonary disease 2. Noncytotoxic drugs. Am Rev Respir Dis 133: 488-505, 1986
  3. Pirmohamed M, Allot r, Green VJ, Kitteringham NR, chadwick D, Park BKAD. Lymphocyte microsomal epoxide hydrolase in patients on carbamazepine therapy. Br J Clin Pharmacol 37 (6): 577-8, 1994
  4. Furst SM, Uetrecht JP. The effect of carbamazepine and its metabolite, 9-acridine carboxaldehyde, on immune cell function in vitro. Int J Immunopharmacol 17 (5): 445-52, 1995.